This section is not available in the published analysis.
LIVMARLI: Audience
LIVMARLI is a transformative medicine developed by Mirum Pharmaceuticals aimed at treating rare liver diseases. It is designed to provide hope and improve the quality of life for patients and their families affected by these conditions.